NEW ORLEANS, December 26, 2025 – Ochsner Health is strategically investing in artificial intelligence, prioritizing gains in productivity and administrative efficiency to support its clinicians, rather than chasing immediate financial returns. The New orleans-based health system is taking a pragmatic approach to AI implementation, focusing on areas where the technology can demonstrably improve workflows and reduce burden.
- Ochsner Health is prioritizing AI investments that improve clinician sustainability and administrative efficiency.
- Ambient documentation technology has received positive feedback from physicians,improving work-life balance.
- The health system is seeing clear financial returns in areas like pharmacy automation and revenue cycle management.
- A risk-based approach guides AI deployment, with stricter standards for patient-facing applications.
- Adoption and operational ownership are crucial for long-term AI success.
Amy Trainor, CIO of Ochsner Health, explained that the system is deliberate in its approach, recognizing that the value of AI isn’t always promptly reflected on a balance sheet. “While not a hard ROI, the, work-life balance, or work-life harmony as I like to call it, is really amazing, and the doctors really do love it,” Trainor said during an appearance on a healthcare podcast.
Ambient documentation technology is currently in a “spread and scale” phase at Ochsner, with the focus on physician adoption and time savings. This investment is viewed as foundational, supporting clinician retention and long-term workforce stability.
Beyond the Clinic: Streamlining Administrative Tasks
while clinician-facing tools offer critically important benefits, Ochsner is also realizing more immediate financial returns through AI-powered automation in administrative and revenue cycle processes. The risk profile is lower in these areas,leading to a faster realization of value.
“We are doing some really great revenue cycle pharmacy authorization automation that’s saving our pharmacists a ton of time,” Trainor said.This automation, while operating within a clinical domain, primarily addresses administrative tasks, freeing up pharmacists to focus on higher-value patient care and accelerating medication access.
Ochsner continues to leverage AI-driven models to enhance quality and operational performance. Looking ahead, trainor anticipates an acceleration in the pace and scale of AI-driven ROI, particularly on the back-office side of the association.”I can onyl imagine if I was saying this next year what that would look like,” she said. “We would probably double the things that we’re using AI for.”
A Measured Approach to AI Implementation
Trainor and her team are emphasizing disciplined expansion over rapid deployment. Ochsner maintains a clear separation between clinical/patient-facing AI applications and administrative use cases, applying more rigorous evaluation standards to those directly impacting patient care.
“In the clinical patient-facing, physician-facing and nurse-facing work, we want to make sure AI is following all of our principles,” Trainor said. “We’re QA-ing it.We want to understand how good the AI is.”
This risk-based strategy allows ochsner to pursue faster ROI in areas like revenue cycle management and administrative burden reduction while simultaneously building trust with clinicians.Strategic prioritization also considers the health system’s unique market realities, including patient demographics, clinician availability, regional economics, and payer mix.
“How do we make sure we’re spending our dollars that give our physicians, clinicians, and our patients the best use of healthcare and technology?” Trainor asked.
Ultimately, Trainor believes that sustainable ROI will depend as much on adoption and operational ownership as it does on the technology itself.”Adoption is the key to success, in AI deployment for sure,” she said.